In both LBC and DGC, CDH1 inactivation can be an early initiating event [7, 8], whereas in other tumour types including prostate, lung, ovarian and colon, its downregulation is usually considered to be a late event that promotes an increase in invasive capacity [9]. This evidence concerns the gene CDH1 and neoplasm.